Feedback / Questions
SUDO-550 - Sudo Biosci
https://www.businesswire.com/news/home/20241202300740/en/Sudo-Biosciences-Announces-First-Participants-Dosed-in-Phase-1-Trial-of-Brain-Penetrant-Allosteric-TYK2-Inhibitor-SUDO-550
Dec 2, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next